» Articles » PMID: 8773594

Neurodegenerative Disorders with Extensive Tau Pathology: a Comparative Study and Review

Overview
Journal Ann Neurol
Specialty Neurology
Date 1996 Aug 1
PMID 8773594
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Many neurodegenerative disorders with onset in mid to late adult life present diagnostic challenges to clinicians and pathologists alike. A distinguishing neuropathological feature has traditionally been the presence or absence of neurofibrillary tangles. Recent biochemical and molecular biological studies have identified the microtubule-binding protein tau as the predominant component of these and related inclusions, and have provided powerful new reagents for the study of neurodegenerative diseases. Several diseases previously considered distinct pathophysiological entities contain similar tau-immunoreactive lesions, but qualitative and regional anatomical differences in vulnerability can differentiate the disorders. Comparison of tau-immunoreactive lesions in three relatively uncommon neurodegenerative diseases-progressive supranuclear palsy, Pick's disease, and corticobasal degeneration-illustrates the types of analyses that demonstrate unexpected pathological similarities, but also fundamental differences between these disorders. These results have important implications for the differential diagnosis of disorders containing tau-immunoreactive lesions, including Alzheimer's disease.

Citing Articles

Cerebral hypoperfusion reduces tau accumulation.

Gheni G, Shinohara M, Masuda-Suzukake M, Shindo A, Watanabe A, Kawai K Ann Clin Transl Neurol. 2024; 12(1):69-85.

PMID: 39621511 PMC: 11752094. DOI: 10.1002/acn3.52247.


Tau protein profiling in tauopathies: a human brain study.

Lantero-Rodriguez J, Camporesi E, Montoliu-Gaya L, Gobom J, Piotrowska D, Olsson M Mol Neurodegener. 2024; 19(1):54.

PMID: 39026372 PMC: 11264707. DOI: 10.1186/s13024-024-00741-9.


Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a knock-in tauopathy model.

Bukhari H, Nithianandam V, Battaglia R, Cicalo A, Sarkar S, Comjean A Genome Res. 2024; 34(4):590-605.

PMID: 38599684 PMC: 11146598. DOI: 10.1101/gr.278576.123.


Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in a knock-in tauopathy model.

Bukhari H, Nithianandam V, Battaglia R, Cicalo A, Sarkar S, Comjean A bioRxiv. 2024; .

PMID: 38352559 PMC: 10862891. DOI: 10.1101/2024.02.02.578624.


Decoding Neurodegeneration: A Comprehensive Review of Molecular Mechanisms, Genetic Influences, and Therapeutic Innovations.

Voicu V, Tataru C, Toader C, Covache-Busuioc R, Glavan L, Bratu B Int J Mol Sci. 2023; 24(16).

PMID: 37629187 PMC: 10455143. DOI: 10.3390/ijms241613006.